Xie Tian-Hao, Fu Yan, Jin Xiao-Shi, Ha Si-Ning, Ren Xiang-Xiang, Sun Xin-Li, Niu Zheng
Department of General Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Basic Research Key Laboratory of General Surgery for Digital Medicine, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Front Med (Lausanne). 2025 Aug 18;12:1614914. doi: 10.3389/fmed.2025.1614914. eCollection 2025.
Horner syndrome (HS), a rare complication of endoscopic thyroid surgery (ETS), manifests as ptosis, miosis, and anhidrosis resulting from oculosympathetic pathway disruption. This study explores HS etiology through two case reports and literature analysis. Case 1 involved a 43-year-old female who underwent unilateral thyroidectomy via a bilateral areolar approach for a thyroid oncocytic adenoma. On postoperative day 1, ptosis and miosis were observed, and the patient was diagnosed with HS. Despite initial glucocorticoid and neurotrophic therapy, symptoms resolved spontaneously by 6 months. Case 2 involved a 36-year-old female with papillary thyroid carcinoma treated via ETS with central lymph node dissection. Transient ptosis and miosis occurred postoperatively and resolved completely after a 6-day course of steroid treatment. Both cases highlighted HS as a complication linked to intraoperative cervical sympathetic chain (CSC) injury, likely due to retractor-induced compression, thermal damage from energy devices, or anatomical variations. A literature review identified only nine prior ETS-related HS cases, emphasizing its rarity (incidence: 0.03%-0.48%). Mechanisms include CSC compression caused by hematoma, edema, or inflammation in confined surgical spaces, with most symptoms resolving as these subside. Differential diagnosis requires excluding intracranial, spinal, or vascular pathologies. Pharmacologic tests utilizing drugs such as Apraclonidine, Cocaine, and Hydroxyamphetamine aid in the diagnosis of HS, while short-term use of steroids and neurotrophins may expedite recovery. Persistent HS beyond 1 year diminishes the likelihood of recovery, necessitating surgical correction for ptosis. ETS, favored for cosmetic outcomes, demands meticulous CSC preservation during dissection, particularly near the superior cervical ganglion. Preoperative patient counseling about HS risk is crucial. This study underscores HS as non-life-threatening yet distressing complication, advocating for refined surgical techniques and heightened anatomical awareness to avoid CSC injury during ETS.
霍纳综合征(HS)是内镜甲状腺手术(ETS)的一种罕见并发症,表现为因眼交感神经通路中断而导致的上睑下垂、瞳孔缩小和无汗。本研究通过两例病例报告和文献分析探讨HS的病因。病例1为一名43岁女性,因甲状腺嗜酸细胞腺瘤经双侧乳晕入路行单侧甲状腺切除术。术后第1天观察到上睑下垂和瞳孔缩小,患者被诊断为HS。尽管最初采用了糖皮质激素和神经营养治疗,但症状在6个月时自发缓解。病例2为一名36岁女性,患有甲状腺乳头状癌,通过ETS加中央淋巴结清扫术进行治疗。术后出现短暂的上睑下垂和瞳孔缩小,经6天的类固醇治疗后完全缓解。两例病例均强调HS是一种与术中颈交感神经链(CSC)损伤相关的并发症,可能是由于牵开器引起的压迫、能量设备的热损伤或解剖变异所致。文献综述仅发现9例先前与ETS相关的HS病例,强调了其罕见性(发生率:0.03%-0.48%)。其机制包括有限手术空间内血肿、水肿或炎症引起的CSC压迫,随着这些情况的消退,大多数症状会缓解。鉴别诊断需要排除颅内、脊髓或血管病变。使用阿可乐定、可卡因和羟苯丙胺等药物进行药理学测试有助于HS的诊断,而短期使用类固醇和神经营养药物可能会加快恢复。HS持续超过1年则恢复的可能性降低,需要对上睑下垂进行手术矫正。ETS因其美容效果而受到青睐,在解剖过程中需要精心保护CSC,尤其是在上颈神经节附近。术前对患者进行HS风险的咨询至关重要。本研究强调HS是一种虽不危及生命但令人痛苦的并发症,主张采用精细的手术技术并提高解剖学意识,以避免在ETS期间发生CSC损伤。